Ejemplares similares: [Prediction of histological liver damage in asymptomatic alcoholic patients by means of clinical and laboratory data].
- [Alcoholic liver disease. I. Pathophysiology (author's transl)].
- [A clinico-pathological study of the liver damage in alcoholic patients].
- [Alcoholic liver disease. II: Pathologic and clinical aspects (author's transl)].
- Content of Hepatic Reduced Glutathione in Chronic Alcoholic Patients: Influence of the Length of Abstinence and Liver Necrosis
- [Clinical and metabolic disorders in alcoholic hepatic damage].
- [Alcoholism and liver damage].
Tópico: Internal medicine
- COVID-19 among Amazonian indigenous in Peru: mortality, incidence, and clinical characteristics
- Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV
- Caracterización epidemiológica, clínica y de laboratorio de esporotricosis en pacientes de un hospital de tercer nivel en Lima-Perú, entre los años 1991 y 2014
- Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial
- Medication Possession Ratio Predicts Antiretroviral Regimens Persistence in Peru
- Faculty Opinions recommendation of Acute and potentially life-threatening tropical diseases in western travelers--a GeoSentinel multicenter study, 1996-2011.
Tópico: Medicine
- Matters of life and death : human dilemmas in the light of Christian faith
- COVID-19 among Amazonian indigenous in Peru: mortality, incidence, and clinical characteristics
- COVID-19 among Amazonian indigenous in Peru
- Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV
- Caracterización epidemiológica, clínica y de laboratorio de esporotricosis en pacientes de un hospital de tercer nivel en Lima-Perú, entre los años 1991 y 2014
- Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial
Autor: Iturriaga, H
- [Major histocompatibility system as a risk factor for alcoholic liver disease].
- Nutritional support in hospitalized patients with alcoholic liver disease.
- [Alcoholic liver disease. II: Pathologic and clinical aspects (author's transl)].
- [Ethanol metabolism in alcoholic patients. Various factors affecting in vivo ethanol metabolism].
- Some effects of ethanol on normal and pathologic livers.
- [A clinico-pathological study of the liver damage in alcoholic patients].